Compare BLCO & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | ORA |
|---|---|---|
| Founded | 1853 | 1965 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.8B |
| IPO Year | 2022 | 2004 |
| Metric | BLCO | ORA |
|---|---|---|
| Price | $17.36 | $87.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $19.39 | ★ $126.33 |
| AVG Volume (30 Days) | 482.6K | ★ 691.4K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $5,101,000,000.00 | $719,267,000.00 |
| Revenue This Year | $7.68 | $19.26 |
| Revenue Next Year | $5.95 | N/A |
| P/E Ratio | ★ N/A | $78.19 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $14.44 | $85.77 |
| 52 Week High | $18.92 | $146.39 |
| Indicator | BLCO | ORA |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 40.93 |
| Support Level | $16.71 | $87.06 |
| Resistance Level | $17.54 | $93.96 |
| Average True Range (ATR) | 0.52 | 2.47 |
| MACD | 0.07 | 0.22 |
| Stochastic Oscillator | 93.10 | 23.93 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: the Electricity Segment. where the company develops, builds, owns, and operates geothermal, solar PV, and recovered energy-based power plants in the United States and geothermal power plants in other countries and sells the electricity generated. Product Segment includes designing, manufacturing, and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement, and construction of geothermal & recovered energy-based power plants. Energy Storage Segment includes owning & operating grid-connected which provide capacity, energy, & ancillary services directly to the electric grid.